For at vurdere knoglekvaliteten, blev der efter 2 års behandling taget knoglebiopsier fra 71 postmenopausale kvinder.
To assess bone quality, bone biopsies were obtained from 71 postmenopausal women enrolled in BMD trials after 2 years of treatment.